ADVANCE - An open-label study evaluating the Pharmacokinetiks and Tolerability of Lu AA21004 in connection with multiple oral dosing of Lu AA21004 in child and adolescent patients with a DSM-IV diagnosis of Depressive or Anxiety Disorder